In light of a recent publication focusing on the timing of alterations developed during the acquisition of cetuximab resistance in an HNSCC cell line [53], the mutations in genes associated with epigenetic regulation, such as KAT6A and NSD1, identified in the targeted sequencing analysis may be of particular interest. This evidence concerns the gene NSD1 and head and neck squamous cell carcinoma.